Chimeric Therapeutics Ltd
ASX:CHM
Balance Sheet
Balance Sheet Decomposition
Chimeric Therapeutics Ltd
Chimeric Therapeutics Ltd
Balance Sheet
Chimeric Therapeutics Ltd
| Jun-2020 | Jun-2021 | Jun-2022 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
0
|
22
|
18
|
|
| Cash |
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
22
|
18
|
|
| Total Receivables |
0
|
0
|
3
|
|
| Accounts Receivables |
0
|
0
|
3
|
|
| Other Receivables |
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
|
| Total Current Assets |
0
|
23
|
21
|
|
| PP&E Net |
0
|
0
|
0
|
|
| Intangible Assets |
0
|
14
|
14
|
|
| Long-Term Investments |
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
37
+36 504 800%
|
35
-4%
|
|
| Liabilities | ||||
| Accounts Payable |
0
|
3
|
5
|
|
| Accrued Liabilities |
0
|
0
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
4
|
2
|
|
| Total Current Liabilities |
0
|
7
|
9
|
|
| Long-Term Debt |
0
|
4
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
11
+17 672%
|
9
-19%
|
|
| Equity | ||||
| Common Stock |
0
|
37
|
52
|
|
| Retained Earnings |
0
|
12
|
26
|
|
| Total Equity |
0
N/A
|
25
N/A
|
26
+2%
|
|
| Total Liabilities & Equity |
0
N/A
|
37
+36 504 800%
|
35
-4%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
343
|
343
|
425
|
|